Alavi, JB, Schoenfeld, D, Skeel, RT, Kirkwood, R, Tsung, L, Marsh, JC.Phase II trial of spirogermanium and vindesine in malignant glioma.„Am J Clin Oncol”.12.1,s.8-10,1989. PMID: 2912024.
Kuebler, JP, Tormey, DC, Harper, GR, et al.Phase II study of spirogermanium in advanced breast cancer.„Cancer Treat Rep”.68.12,s.1515-1516,1984. PMID: 6509457.
Lad, TE, Blough, RR, Evrard, M, et al.Phase II trial of spirogermanium in advanced non-small cell lung cancer. An Illinois Cancer Council Study.„Invest New Drugs”.7.2-3,s.223-224,1989. PMID: 2551841.
Novik, Y, Ryan, LM, Haller, DG, et al.Phase II protocol for the evaluation of new treatments in patients with advanced gastric carcinoma: results of ECOG 5282.„Med Oncol”.16.4,s.261-266,1999. PMID: 10618689.
Badger AM, Schwartz DA, Picker DH, Dorman JW, Bradley FC, Cheeseman EN, DiMartino MJ, Hanna N, Mirabelli CK.Antiarthritic and suppressor cell inducing activity of azaspiranes: structure-function relationships of a novel class of immunomodulatory agents.„J Med Chem”.33.11,s.2963-2970,1990. PMID: 2146392.